Asia-Pacific Pharmaceuticals (002370.SZ) released its half-year financial results, with a net profit attributable to the parent company of 105 million yuan, an increase of 1820.97%

Finance and Economics APP News, Asia Pacific Pharmaceutical (002370.SZ) released its 2025 semi-annual report. The company's operating income was 152 million yuan, a decrease of 31.48% year-on-year. Net profit attributable to shareholders of the listed company was 105 million yuan, an increase of 1820.97% year-on-year. The net loss attributable to shareholders of the listed company after deducting non-recurring gains and losses was 48.8622 million yuan, an increase of 524.31% year-on-year. Basic earnings per share were 0.14 yuan.